Monobactam Antibacterial [EPC]

Monobactam Antibacterial [EPC] was reported 2727 times

Drugs of the Monobactam Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ADRENERGIC SYNDROME 7 0.0864
1 BACTERIAL DISEASE CARRIER 41 0.0562
2 NEONATAL INTESTINAL PERFORATION 2 0.0556
3 PSEUDOMONAS BRONCHITIS 3 0.0435
4 SEPTIC CARDIOMYOPATHY 2 0.0400
5 PENICILLIUM INFECTION 6 0.0333
6 SUPERINFECTION 47 0.0313
7 ACINETOBACTER SEPSIS 2 0.0312
8 BRONCHIAL SECRETION RETENTION 39 0.0306
9 HYPOTENSIVE TRANSFUSION REACTION 2 0.0303
10 ANTITHROMBIN III DEFICIENCY 2 0.0225
11 PULMONARY HAEMORRHAGE NEONATAL 2 0.0217
12 VASCULAR ACCESS SITE INFECTION 2 0.0208
13 DISSEMINATED MUCORMYCOSIS 8 0.0203
14 SLEEP PHASE RHYTHM DISTURBANCE 3 0.0200
15 PARAINFLUENZA VIRUS INFECTION 2 0.0194
16 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 7 0.0172
17 URINARY FISTULA 2 0.0167
18 HYPNOPOMPIC HALLUCINATION 2 0.0161
19 HER2 POSITIVE BREAST CANCER 6 0.0160
20 VANCOMYCIN INFUSION REACTION 6 0.0159
21 NEPHRITIS ALLERGIC 6 0.0151
22 GRAM STAIN POSITIVE 3 0.0146
23 RADIATION ASSOCIATED PAIN 3 0.0144
24 HAEMOSTASIS 2 0.0123
25 LACTOBACILLUS INFECTION 2 0.0122
26 SINUS OPERATION 29 0.0122
27 INFECTED NEOPLASM 3 0.0120
28 ENDOMETRIAL CANCER STAGE I 2 0.0120
29 VESICAL FISTULA 3 0.0119
30 CARNITINE DEFICIENCY 2 0.0117
31 PRE-EXISTING DISEASE 5 0.0103
32 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 56 0.0103
33 LABORATORY TEST INTERFERENCE 8 0.0102
34 CELLULITIS GANGRENOUS 2 0.0102
35 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
36 FUNGAL SEPSIS 8 0.0096
37 EOSINOPHILIA 160 0.0091
38 DISTAL INTESTINAL OBSTRUCTION SYNDROME 3 0.0089
39 NECROTISING SOFT TISSUE INFECTION 2 0.0087
40 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 2 0.0086
41 PSEUDOMONAS TEST POSITIVE 7 0.0085
42 DEVICE INTERACTION 2 0.0084
43 CARDIAC VALVE VEGETATION 4 0.0082
44 EPSTEIN-BARR VIRUS TEST POSITIVE 5 0.0079
45 BLOOD CORTISOL INCREASED 2 0.0075
46 OSTEOMYELITIS BACTERIAL 2 0.0073
47 ENTEROCOLITIS BACTERIAL 2 0.0072
48 CANDIDA TEST POSITIVE 3 0.0072
49 DEVICE RELATED THROMBOSIS 7 0.0071
50 BURKHOLDERIA CEPACIA COMPLEX INFECTION 2 0.0070
51 ENGRAFT FAILURE 2 0.0070
52 ENTEROCOCCAL BACTERAEMIA 7 0.0066
53 NONSPECIFIC REACTION 36 0.0066
54 VESTIBULAR DISORDER 8 0.0065
55 SKIN TEST POSITIVE 6 0.0064
56 PROTHROMBIN TIME RATIO DECREASED 4 0.0064
57 ZYGOMYCOSIS 3 0.0064
58 MICROTIA 2 0.0063
59 CNS VENTRICULITIS 2 0.0061
60 SPUTUM ABNORMAL 4 0.0060
61 STENOTROPHOMONAS INFECTION 8 0.0059
62 PNEUMONIA PSEUDOMONAL 9 0.0059
63 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45 0.0058
64 PNEUMONITIS CHEMICAL 2 0.0057
65 RED MAN SYNDROME 5 0.0057
66 PANCREATIC INSUFFICIENCY 2 0.0056
67 SPUTUM INCREASED 12 0.0055
68 SCOLIOSIS 34 0.0055
69 RETINOPATHY OF PREMATURITY 3 0.0054
70 CHOLESTATIC LIVER INJURY 12 0.0054
71 MULTIPLE-DRUG RESISTANCE 16 0.0052
72 BRONCHOPULMONARY DYSPLASIA 4 0.0050
73 TRICHOSPORON INFECTION 2 0.0049
74 BLOOD BILIRUBIN DECREASED 3 0.0049
75 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 120 0.0047
76 HEPATIC CYTOLYSIS 59 0.0046
77 ALLERGIC OEDEMA 3 0.0046
78 MUCORMYCOSIS 12 0.0046
79 PATHOGEN RESISTANCE 42 0.0046
80 ENCEPHALITIS CYTOMEGALOVIRUS 2 0.0046
81 ATELECTASIS 44 0.0045
82 ABDOMINAL SEPSIS 4 0.0045
83 CLOSTRIDIUM TEST POSITIVE 10 0.0045
84 ANAEMIA NEONATAL 2 0.0041
85 PSEUDOMEMBRANOUS COLITIS 9 0.0040
86 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
87 SEPSIS SYNDROME 2 0.0040
88 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
89 ACUTE INTERSTITIAL PNEUMONITIS 2 0.0038
90 PSEUDOMONAS INFECTION 32 0.0037
91 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
92 HYPEREOSINOPHILIC SYNDROME 2 0.0037
93 VASOPLEGIA SYNDROME 6 0.0037
94 IMMUNOGLOBULINS DECREASED 5 0.0036
95 RASH MACULO-PAPULAR 81 0.0036
96 TOXIC EPIDERMAL NECROLYSIS 55 0.0036
97 BLOOD PH INCREASED 2 0.0036
98 LINEAR IGA DISEASE 6 0.0036
99 LUNG INFECTION PSEUDOMONAL 2 0.0036
100 EMPYEMA 7 0.0035
101 PSEUDOMONAL BACTERAEMIA 3 0.0035
102 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
103 AXONAL NEUROPATHY 3 0.0034
104 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
105 BRONCHOSPASM 47 0.0033
106 CYSTIC FIBROSIS 18 0.0032
107 MEDICAL DEVICE SITE INFECTION 2 0.0032
108 TOXIC SKIN ERUPTION 32 0.0032
109 BRAIN STEM HAEMORRHAGE 3 0.0032
110 ELECTROCARDIOGRAM T WAVE INVERSION 7 0.0032
111 ELECTROCARDIOGRAM CHANGE 3 0.0032
112 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
113 ENTEROCOCCAL INFECTION 15 0.0031
114 MIXED LIVER INJURY 9 0.0030
115 TUMOUR FLARE 2 0.0029
116 ACUTE PROMYELOCYTIC LEUKAEMIA 3 0.0029
117 AGRANULOCYTOSIS 54 0.0029
118 PNEUMONIA FUNGAL 11 0.0028
119 CHYLOTHORAX 2 0.0028
120 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
121 PERIRECTAL ABSCESS 3 0.0027
122 LEUKOCYTOSIS 47 0.0026
123 VASCULITIC RASH 2 0.0026
124 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 6 0.0026
125 SYSTEMIC MYCOSIS 3 0.0026
126 EXTRADURAL ABSCESS 2 0.0025
127 SPUTUM CULTURE POSITIVE 2 0.0025
128 BACTERIAL SEPSIS 8 0.0025
129 OTITIS EXTERNA 3 0.0025
130 CRYPTOCOCCOSIS 4 0.0025
131 COLLAPSE OF LUNG 2 0.0024
132 SEPTIC EMBOLUS 2 0.0024
133 CULTURE POSITIVE 2 0.0024
134 BRAIN ABSCESS 6 0.0024
135 SEPTIC SHOCK 103 0.0024
136 HEPATIC HAEMORRHAGE 2 0.0023
137 HYPERTRANSAMINASAEMIA 16 0.0023
138 DRUG CLEARANCE DECREASED 3 0.0023
139 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 39 0.0023
140 IMPAIRED QUALITY OF LIFE 33 0.0023
141 MITRAL VALVE DISEASE 4 0.0023
142 HEPATOCELLULAR INJURY 32 0.0023
143 PARVOVIRUS B19 INFECTION 2 0.0022
144 CANDIDA SEPSIS 2 0.0022
145 EOSINOPHILIC PNEUMONIA 7 0.0022
146 DRUG RESISTANCE 57 0.0022
147 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
148 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
149 ABULIA 2 0.0022
150 KLEBSIELLA BACTERAEMIA 2 0.0021
151 LONG QT SYNDROME 5 0.0021
152 CHOLESTASIS 39 0.0020
153 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
154 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
155 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
156 APPENDICITIS PERFORATED 5 0.0020
157 BRAIN STEM INFARCTION 2 0.0020
158 RENAL TUBULAR NECROSIS 19 0.0019
159 PULMONARY HAEMORRHAGE 15 0.0019
160 FUNGAEMIA 3 0.0019
161 HYPOPERFUSION 2 0.0019
162 VASCULAR CALCIFICATION 2 0.0019
163 ACINETOBACTER INFECTION 2 0.0018
164 SHOCK 42 0.0018
165 RASH MORBILLIFORM 5 0.0018
166 VANISHING BILE DUCT SYNDROME 2 0.0018
167 MULTI-ORGAN FAILURE 31 0.0018
168 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
169 CLEFT LIP AND PALATE 2 0.0018
170 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
171 ENTEROBACTER INFECTION 3 0.0018
172 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
173 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
174 LOCALISED OEDEMA 8 0.0017
175 EPIDIDYMITIS 2 0.0017
176 PROCALCITONIN INCREASED 2 0.0017
177 NECROTISING FASCIITIS 6 0.0017
178 FEBRILE INFECTION 2 0.0017
179 OBSESSIVE THOUGHTS 3 0.0017
180 PRETERM PREMATURE RUPTURE OF MEMBRANES 2 0.0017
181 REFLUX GASTRITIS 2 0.0017
182 DERMATITIS BULLOUS 12 0.0017
183 RIB FRACTURE 34 0.0017
184 CEREBRAL ARTERY EMBOLISM 2 0.0016
185 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
186 DERMATITIS EXFOLIATIVE 8 0.0016
187 NASAL PRURITUS 2 0.0016
188 HYPERPARATHYROIDISM SECONDARY 4 0.0016
189 ENDOCARDITIS 8 0.0016
190 AORTIC ARTERIOSCLEROSIS 4 0.0016
191 SLOW RESPONSE TO STIMULI 2 0.0015
192 EXFOLIATIVE RASH 4 0.0015
193 ACUTE RESPIRATORY FAILURE 29 0.0015
194 INTESTINAL DILATATION 2 0.0015
195 TUBULOINTERSTITIAL NEPHRITIS 28 0.0015
196 HYPOPHYSITIS 3 0.0015
197 BRONCHIECTASIS 10 0.0015
198 EFFUSION 2 0.0015
199 RENAL ARTERY STENOSIS 2 0.0015
200 NEUTROPENIC COLITIS 3 0.0014
201 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
202 PLEURITIC PAIN 4 0.0014
203 VASCULAR PURPURA 2 0.0014
204 STAPHYLOCOCCAL SEPSIS 7 0.0014
205 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
206 VASCULAR INJURY 2 0.0014
207 SLEEP PARALYSIS 2 0.0014
208 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 13 0.0014
209 NOSOCOMIAL INFECTION 3 0.0014
210 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
211 HEPATITIS FULMINANT 4 0.0013
212 HYPERCAPNIA 4 0.0013
213 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
214 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
215 INFECTIOUS PLEURAL EFFUSION 2 0.0013
216 ORAL INFECTION 5 0.0013
217 ESCHERICHIA BACTERAEMIA 3 0.0013
218 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
219 NEUTROPENIC SEPSIS 9 0.0013
220 WEIGHT ABNORMAL 3 0.0012
221 PURPURA 11 0.0012
222 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
223 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
224 COSTOCHONDRITIS 2 0.0012
225 GLOMERULONEPHRITIS 3 0.0012
226 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
227 HYPERVOLAEMIA 6 0.0012
228 HYPERNATRAEMIA 6 0.0012
229 PERSECUTORY DELUSION 3 0.0012
230 EOSINOPHIL COUNT INCREASED 10 0.0012
231 SYSTEMIC CANDIDA 3 0.0012
232 UROSEPSIS 11 0.0012
233 LEUKAEMIA RECURRENT 2 0.0012
234 BUNDLE BRANCH BLOCK LEFT 5 0.0012
235 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
236 ABDOMINAL INFECTION 3 0.0012
237 PURULENT DISCHARGE 5 0.0012
238 BLOOD PH DECREASED 2 0.0012
239 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
240 FIXED ERUPTION 2 0.0012
241 CERVICAL SPINAL STENOSIS 2 0.0012
242 SPUTUM DISCOLOURED 11 0.0012
243 BLOOD CHLORIDE INCREASED 2 0.0012
244 INCORRECT STORAGE OF DRUG 2 0.0012
245 APLASTIC ANAEMIA 6 0.0011
246 OTORRHOEA 2 0.0011
247 HYPERSENSITIVITY VASCULITIS 3 0.0011
248 PULMONARY FUNCTION TEST DECREASED 5 0.0011
249 COAGULOPATHY 19 0.0011
250 BLOOD ALBUMIN DECREASED 9 0.0011
251 GASTROINTESTINAL OEDEMA 2 0.0011
252 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
253 RESPIRATORY FAILURE 82 0.0011
254 TRANSPLANT DYSFUNCTION 2 0.0011
255 HYPERLACTACIDAEMIA 3 0.0011
256 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
257 HAEMOLYTIC ANAEMIA 10 0.0011
258 GRAFT VERSUS HOST DISEASE 8 0.0011
259 HAEMOPTYSIS 31 0.0011
260 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
261 PNEUMONIA KLEBSIELLA 2 0.0011
262 OTOTOXICITY 2 0.0011
263 PUPILLARY REFLEX IMPAIRED 2 0.0011
264 NEPHROGENIC ANAEMIA 5 0.0011
265 HYPOXIA 38 0.0011
266 PLASMACYTOMA 2 0.0011
267 HYPERBILIRUBINAEMIA 11 0.0011
268 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
269 CYSTOID MACULAR OEDEMA 2 0.0011
270 INTERVERTEBRAL DISCITIS 2 0.0011
271 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
272 FORCED EXPIRATORY VOLUME DECREASED 3 0.0011
273 CIRCULATORY COLLAPSE 18 0.0011
274 GENERALISED ERYTHEMA 6 0.0011
275 BONE MARROW TRANSPLANT 2 0.0011
276 HYPOPROTEINAEMIA 2 0.0011
277 THROMBOCYTOPENIA 117 0.0010
278 HEPATIC MASS 2 0.0010
279 STEVENS-JOHNSON SYNDROME 23 0.0010
280 TRANSAMINASES INCREASED 23 0.0010
281 HAEMOTHORAX 3 0.0010
282 RASH VESICULAR 5 0.0010
283 BICYTOPENIA 2 0.0010
284 LUNG INFILTRATION 9 0.0010
285 MULTI-ORGAN DISORDER 2 0.0010
286 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
287 CELL DEATH 2 0.0010
288 BLOOD CULTURE POSITIVE 3 0.0010
289 METABOLIC ENCEPHALOPATHY 3 0.0010
290 CANDIDIASIS 4 0.0010
291 CYSTITIS HAEMORRHAGIC 4 0.0010
292 RESPIRATORY DISTRESS 27 0.0010
293 LUNG INFECTION 15 0.0010
294 FAILURE TO THRIVE 5 0.0010
295 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
296 FACE OEDEMA 16 0.0009
297 CANDIDA INFECTION 16 0.0009
298 LIP OEDEMA 4 0.0009
299 BILE DUCT STONE 3 0.0009
300 PNEUMONIA VIRAL 3 0.0009
301 END STAGE RENAL DISEASE 17 0.0009
302 HYPERPHOSPHATAEMIA 2 0.0009
303 THROMBOTIC MICROANGIOPATHY 9 0.0009
304 LYMPHOPENIA 13 0.0009
305 HAEMODYNAMIC INSTABILITY 7 0.0009
306 BIPOLAR I DISORDER 2 0.0009
307 MIDDLE EAR EFFUSION 2 0.0009
308 CYTOLYTIC HEPATITIS 3 0.0009
309 CARDIAC FAILURE ACUTE 6 0.0009
310 STREPTOCOCCAL INFECTION 5 0.0009
311 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
312 BK VIRUS INFECTION 3 0.0009
313 FEBRILE NEUTROPENIA 59 0.0009
314 DISTRIBUTIVE SHOCK 2 0.0009
315 PNEUMOTHORAX 14 0.0009
316 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
317 VASCULAR DEVICE INFECTION 4 0.0009
318 RESPIRATION ABNORMAL 6 0.0009
319 CYTOMEGALOVIRUS COLITIS 2 0.0009
320 MYASTHENIA GRAVIS 7 0.0009
321 RALES 5 0.0009
322 BILIRUBIN CONJUGATED INCREASED 2 0.0009
323 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
324 ESCHERICHIA INFECTION 7 0.0009
325 PULMONARY INFARCTION 2 0.0008
326 BACTERAEMIA 10 0.0008
327 APPARENT DEATH 3 0.0008
328 ACUTE KIDNEY INJURY 127 0.0008
329 BREATH ODOUR 2 0.0008
330 AGGRESSION 41 0.0008
331 HAEMATOLOGICAL INFECTION 2 0.0008
332 PREMATURE DELIVERY 13 0.0008
333 TRANSPLANT FAILURE 2 0.0008
334 ANURIA 7 0.0008
335 RETROPERITONEAL HAEMORRHAGE 2 0.0008
336 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
337 TACHYPNOEA 11 0.0008
338 ACUTE PSYCHOSIS 2 0.0008
339 SINUS DISORDER 16 0.0008
340 DEVICE INFUSION ISSUE 2 0.0008
341 OLIGURIA 5 0.0008
342 BACTERIAL INFECTION 15 0.0008
343 URINE OUTPUT DECREASED 7 0.0008
344 STEM CELL TRANSPLANT 2 0.0008
345 VASODILATATION 2 0.0008
346 TENDON PAIN 6 0.0008
347 URINARY TRACT INFECTION BACTERIAL 2 0.0008
348 DRUG ERUPTION 14 0.0008
349 VENTRICULAR TACHYCARDIA 13 0.0008
350 HYPERTHERMIA 6 0.0008
351 ELECTROLYTE IMBALANCE 9 0.0008
352 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
353 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
354 RESPIRATORY ACIDOSIS 3 0.0008
355 LUNG OPACITY 2 0.0008
356 WHEEZING 45 0.0008
357 SUDDEN DEATH 8 0.0008
358 RENAL FAILURE 99 0.0007
359 RHINITIS 6 0.0007
360 HYPOCALCAEMIA 14 0.0007
361 ENCEPHALOPATHY 18 0.0007
362 BLOOD PHOSPHORUS INCREASED 2 0.0007
363 CLONUS 2 0.0007
364 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 35 0.0007
365 STAPHYLOCOCCAL INFECTION 24 0.0007
366 DRUG LEVEL INCREASED 12 0.0007
367 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
368 HAEMODIALYSIS 6 0.0007
369 HYPERPYREXIA 3 0.0007
370 ABSCESS LIMB 3 0.0007
371 ALANINE AMINOTRANSFERASE INCREASED 43 0.0007
372 TEARFULNESS 3 0.0007
373 CARDIOGENIC SHOCK 10 0.0007
374 ENTEROCOLITIS 4 0.0007
375 ESCHERICHIA SEPSIS 2 0.0007
376 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
377 RENAL FAILURE ACUTE 29 0.0007
378 ABDOMINAL ABSCESS 3 0.0007
379 RHINITIS ALLERGIC 3 0.0007
380 HYDRONEPHROSIS 5 0.0007
381 BLOOD BILIRUBIN INCREASED 18 0.0007
382 HEPATITIS CHOLESTATIC 4 0.0007
383 SEPSIS 74 0.0007
384 CENTRAL VENOUS CATHETERISATION 2 0.0007
385 OSTEOMYELITIS 12 0.0007
386 BONE MARROW DISORDER 2 0.0007
387 VARICES OESOPHAGEAL 2 0.0007
388 REBOUND ACID HYPERSECRETION 2 0.0007
389 C-REACTIVE PROTEIN INCREASED 24 0.0007
390 KERATITIS 2 0.0007
391 RASH GENERALISED 17 0.0007
392 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
393 ACIDOSIS 5 0.0007
394 MASTICATION DISORDER 2 0.0007
395 DUODENITIS 2 0.0007
396 LIVER INJURY 16 0.0007
397 RECTAL CANCER 2 0.0007
398 RENAL FAILURE CHRONIC 5 0.0006
399 LARYNGEAL OEDEMA 4 0.0006
400 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
401 PORTAL HYPERTENSION 2 0.0006
402 ATRIAL FIBRILLATION 63 0.0006
403 ANHEDONIA 17 0.0006
404 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 46 0.0006
405 ERYTHEMA MULTIFORME 6 0.0006
406 TREATMENT NONCOMPLIANCE 35 0.0006
407 TORSADE DE POINTES 5 0.0006
408 AFFECTIVE DISORDER 5 0.0006
409 PULSE ABSENT 3 0.0006
410 PANCYTOPENIA 35 0.0006
411 HERPES SIMPLEX 4 0.0006
412 OEDEMA MOUTH 2 0.0006
413 INFUSION SITE HAEMORRHAGE 2 0.0006
414 MENINGITIS 4 0.0006
415 CYTOKINE RELEASE SYNDROME 12 0.0006
416 HEPATIC FAILURE 18 0.0006
417 ATRIAL SEPTAL DEFECT 5 0.0006
418 KLEBSIELLA INFECTION 3 0.0006
419 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
420 POSTOPERATIVE WOUND INFECTION 4 0.0006
421 DRUG LEVEL DECREASED 6 0.0006
422 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
423 PALLOR 16 0.0006
424 PNEUMONITIS 16 0.0006
425 BLOOD CREATININE ABNORMAL 2 0.0006
426 HYPOMAGNESAEMIA 8 0.0006
427 EXTRASYSTOLES 4 0.0006
428 PARTIAL SEIZURES 3 0.0006
429 CAROTID ARTERY STENOSIS 2 0.0006
430 HYPERKALAEMIA 20 0.0006
431 BLOOD LACTIC ACID INCREASED 3 0.0006
432 DEPRESSIVE SYMPTOM 2 0.0006
433 FIBRIN D DIMER INCREASED 2 0.0006
434 CONJUNCTIVAL HYPERAEMIA 2 0.0006
435 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
436 BONE LESION 2 0.0006
437 HYDROCEPHALUS 3 0.0006
438 INTESTINAL ISCHAEMIA 3 0.0005
439 NEUTROPENIA 74 0.0005
440 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
441 BONE MARROW FAILURE 11 0.0005
442 LEUKOPENIA 27 0.0005
443 DRUG INTOLERANCE 52 0.0005
444 GENERAL PHYSICAL HEALTH DETERIORATION 62 0.0005
445 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
446 HEART RATE INCREASED 53 0.0005
447 MITRAL VALVE INCOMPETENCE 6 0.0005
448 CHOLECYSTITIS ACUTE 3 0.0005
449 LACTIC ACIDOSIS 17 0.0005
450 ANAPHYLACTIC REACTION 29 0.0005
451 HYPERTONIA 3 0.0005
452 RENAL IMPAIRMENT 44 0.0005
453 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
454 HERPES VIRUS INFECTION 3 0.0005
455 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
456 HAEMOLYSIS 4 0.0005
457 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
458 METABOLIC DISORDER 3 0.0005
459 LIVER FUNCTION TEST ABNORMAL 15 0.0005
460 HYPOALBUMINAEMIA 4 0.0005
461 NEUROTOXICITY 9 0.0005
462 VENOUS THROMBOSIS 2 0.0005
463 PYREXIA 176 0.0005
464 SINUS HEADACHE 3 0.0005
465 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
466 ANAPHYLACTIC SHOCK 13 0.0005
467 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
468 BRAIN INJURY 5 0.0005
469 HYPOKALAEMIA 23 0.0005
470 TACHYCARDIA 44 0.0005
471 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
472 NEUTROPHIL COUNT DECREASED 20 0.0005
473 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
474 PETECHIAE 5 0.0005
475 BLOOD UREA INCREASED 8 0.0005
476 FOLLICULITIS 5 0.0005
477 MULTIPLE INJURIES 3 0.0005
478 HALLUCINATIONS, MIXED 2 0.0005
479 RENAL INJURY 14 0.0005
480 FEBRILE BONE MARROW APLASIA 2 0.0005
481 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
482 AORTIC VALVE INCOMPETENCE 2 0.0005
483 LUNG DISORDER 23 0.0005
484 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
485 HEPATITIS ACUTE 3 0.0005
486 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
487 RASH ERYTHEMATOUS 22 0.0005
488 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
489 ASPERGILLUS INFECTION 3 0.0005
490 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
491 DEVICE RELATED INFECTION 7 0.0005
492 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
493 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
494 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
495 MALNUTRITION 5 0.0004
496 DRUG-INDUCED LIVER INJURY 14 0.0004
497 FEAR 12 0.0004
498 MENINGITIS ASEPTIC 2 0.0004
499 PANCREATITIS ACUTE 10 0.0004
500 ULCER HAEMORRHAGE 3 0.0004
501 STATUS EPILEPTICUS 5 0.0004
502 ABDOMINAL HERNIA 2 0.0004
503 METABOLIC ACIDOSIS 14 0.0004
504 IMMUNE THROMBOCYTOPENIA 2 0.0004
505 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
506 MYOCARDITIS 5 0.0004
507 ISCHAEMIA 2 0.0004
508 HYPOTENSION 87 0.0004
509 ASTHMA 49 0.0004
510 MENTAL STATUS CHANGES 12 0.0004
511 LARGE INTESTINE PERFORATION 3 0.0004
512 RHABDOMYOLYSIS 18 0.0004
513 FORMICATION 3 0.0004
514 PULMONARY TOXICITY 3 0.0004
515 COVID-19 PNEUMONIA 5 0.0004
516 DIALYSIS 6 0.0004
517 SINUS TACHYCARDIA 6 0.0004
518 DEAFNESS 11 0.0004
519 SKIN DISORDER 14 0.0004
520 HYPERLIPIDAEMIA 5 0.0004
521 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
522 FLUID OVERLOAD 6 0.0004
523 PLEURAL EFFUSION 25 0.0004
524 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
525 INCORRECT DOSAGE ADMINISTERED 2 0.0004
526 RENAL CELL CARCINOMA 2 0.0004
527 HEPATOMEGALY 4 0.0004
528 SMALL INTESTINAL OBSTRUCTION 5 0.0004
529 CARDIOMYOPATHY 6 0.0004
530 OEDEMA 22 0.0004
531 EXPIRED DRUG ADMINISTERED 2 0.0004
532 ORGANISING PNEUMONIA 2 0.0004
533 DELIRIUM 14 0.0004
534 HEPATIC FUNCTION ABNORMAL 15 0.0004
535 BLOOD CREATININE INCREASED 26 0.0004
536 LYMPHADENOPATHY 14 0.0004
537 HYPOTHERMIA 4 0.0004
538 PATHOLOGICAL FRACTURE 2 0.0004
539 LIPASE INCREASED 3 0.0004
540 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
541 PHLEBITIS 2 0.0004
542 CEREBRAL ISCHAEMIA 2 0.0004
543 MUSCULOSKELETAL CHEST PAIN 6 0.0004
544 SKIN NECROSIS 2 0.0004
545 ACUTE MYELOID LEUKAEMIA 6 0.0004
546 ACCIDENTAL OVERDOSE 14 0.0004
547 TRANSFUSION 4 0.0004
548 HAEMATURIA 13 0.0004
549 SKIN EXFOLIATION 32 0.0004
550 CARDIAC ARREST 31 0.0004
551 ASCITES 11 0.0004
552 ANAL ABSCESS 2 0.0004
553 GASTRIC ULCER 7 0.0004
554 HEPATIC ENZYME INCREASED 25 0.0004
555 ACUTE HEPATIC FAILURE 5 0.0004
556 PREMATURE BABY 11 0.0004
557 FAECALOMA 2 0.0004
558 SEROTONIN SYNDROME 7 0.0004
559 TREATMENT FAILURE 30 0.0004
560 ANGIOEDEMA 16 0.0004
561 CYTOMEGALOVIRUS INFECTION 6 0.0004
562 NECROSIS 2 0.0004
563 ILLNESS 37 0.0004
564 NEPHROPATHY TOXIC 4 0.0004
565 ADVERSE DRUG REACTION 32 0.0004
566 HAEMATEMESIS 9 0.0004
567 PREMATURE LABOUR 2 0.0004
568 INTERSTITIAL LUNG DISEASE 17 0.0004
569 PYELONEPHRITIS 3 0.0003
570 PERICARDIAL EFFUSION 8 0.0003
571 MUCOSAL INFLAMMATION 9 0.0003
572 VASCULITIS 4 0.0003
573 PALPITATIONS 40 0.0003
574 SPLENOMEGALY 4 0.0003
575 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
576 HYPONATRAEMIA 19 0.0003
577 CARDIOTOXICITY 3 0.0003
578 CHOLECYSTITIS 4 0.0003
579 ODYNOPHAGIA 2 0.0003
580 HAEMORRHAGE INTRACRANIAL 5 0.0003
581 PROTHROMBIN TIME PROLONGED 2 0.0003
582 POLYNEUROPATHY 4 0.0003
583 HEARING IMPAIRED 2 0.0003
584 CONDITION AGGRAVATED 101 0.0003
585 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
586 HOSPITALISATION 50 0.0003
587 PIGMENTATION DISORDER 2 0.0003
588 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
589 CHOLANGITIS 2 0.0003
590 BLOOD PRESSURE INCREASED 49 0.0003
591 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
592 PLATELET COUNT DECREASED 34 0.0003
593 CYANOSIS 5 0.0003
594 BRAIN OEDEMA 4 0.0003
595 CHILLS 37 0.0003
596 ABSCESS 5 0.0003
597 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
598 ANOREXIA 4 0.0003
599 PLATELET COUNT INCREASED 4 0.0003
600 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
601 PULMONARY CONGESTION 4 0.0003
602 LIGAMENT SPRAIN 3 0.0003
603 CHRONIC KIDNEY DISEASE 23 0.0003
604 BLISTER 17 0.0003
605 OXYGEN SATURATION DECREASED 17 0.0003
606 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
607 BRADYCARDIA 16 0.0003
608 RESPIRATORY DISORDER 9 0.0003
609 RASH 131 0.0003
610 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
611 CHOLECYSTITIS CHRONIC 2 0.0003
612 POST-TRAUMATIC STRESS DISORDER 2 0.0003
613 CELLULITIS 15 0.0003
614 COLITIS ISCHAEMIC 2 0.0003
615 LETHARGY 17 0.0003
616 BODY TEMPERATURE INCREASED 6 0.0003
617 COMA 14 0.0003
618 ANAEMIA 56 0.0003
619 SCAR 5 0.0003
620 ECCHYMOSIS 2 0.0003
621 PERITONITIS 6 0.0003
622 ENCEPHALITIS 2 0.0003
623 CEREBRAL INFARCTION 7 0.0003
624 INJECTION SITE DISCOMFORT 3 0.0003
625 INJURY 20 0.0003
626 DUODENAL ULCER 2 0.0003
627 THERMAL BURN 2 0.0003
628 ANXIETY 80 0.0003
629 PNEUMONIA 91 0.0003
630 LIVER FUNCTION TEST INCREASED 6 0.0003
631 PARALYSIS 4 0.0003
632 OEDEMA PERIPHERAL 34 0.0003
633 DECREASED ACTIVITY 3 0.0003
634 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
635 TOOTHACHE 5 0.0003
636 RASH PUSTULAR 2 0.0003
637 ASPIRATION 3 0.0003
638 ORAL DISORDER 2 0.0003
639 PRODUCTIVE COUGH 13 0.0003
640 SKIN ULCER 7 0.0003
641 HYPOPHOSPHATAEMIA 2 0.0003
642 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
643 RESPIRATORY TRACT INFECTION 7 0.0003
644 HEPATIC STEATOSIS 5 0.0003
645 HYPOGLYCAEMIA 13 0.0003
646 RASH PAPULAR 6 0.0003
647 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
648 BLOOD SODIUM DECREASED 5 0.0003
649 MYALGIA 45 0.0003
650 CARDIO-RESPIRATORY ARREST 11 0.0003
651 HAEMOGLOBIN DECREASED 27 0.0003
652 TROPONIN INCREASED 2 0.0003
653 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
654 JAUNDICE 7 0.0003
655 CAESAREAN SECTION 3 0.0003
656 APNOEA 2 0.0003
657 ATAXIA 3 0.0003
658 HAEMATOCRIT DECREASED 5 0.0003
659 TRICUSPID VALVE INCOMPETENCE 2 0.0003
660 SENSORY LOSS 2 0.0002
661 LIVER DISORDER 11 0.0002
662 PRODUCT ADMINISTRATION ERROR 5 0.0002
663 DRUG INTERACTION 39 0.0002
664 SHOCK HAEMORRHAGIC 2 0.0002
665 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
666 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
667 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
668 ILEUS 3 0.0002
669 EMBOLISM 2 0.0002
670 PULMONARY HYPERTENSION 5 0.0002
671 SECRETION DISCHARGE 3 0.0002
672 SENSATION OF FOREIGN BODY 2 0.0002
673 DYSPNOEA 134 0.0002
674 CHEST DISCOMFORT 24 0.0002
675 SKIN HYPERPIGMENTATION 2 0.0002
676 HAEMATOMA 6 0.0002
677 MUSCLE STRAIN 2 0.0002
678 DISEASE PROGRESSION 27 0.0002
679 GASTRITIS 6 0.0002
680 INFECTION 33 0.0002
681 TUMOUR LYSIS SYNDROME 2 0.0002
682 URTICARIA 38 0.0002
683 EXPOSURE DURING PREGNANCY 14 0.0002
684 NERVOUS SYSTEM DISORDER 7 0.0002
685 CEREBRAL HAEMORRHAGE 8 0.0002
686 PULMONARY OEDEMA 10 0.0002
687 THERAPY NON-RESPONDER 10 0.0002
688 SINUS CONGESTION 3 0.0002
689 THROAT TIGHTNESS 6 0.0002
690 OFF LABEL USE 194 0.0002
691 DRUG TOXICITY 3 0.0002
692 PNEUMONIA BACTERIAL 2 0.0002
693 RESPIRATORY ARREST 6 0.0002
694 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
695 URINARY TRACT INFECTION 37 0.0002
696 ORAL DISCOMFORT 3 0.0002
697 ABDOMINAL PAIN 50 0.0002
698 HEPATIC CIRRHOSIS 4 0.0002
699 SEASONAL ALLERGY 3 0.0002
700 NEUROPATHY PERIPHERAL 20 0.0002
701 FUNGAL INFECTION 7 0.0002
702 RED BLOOD CELL COUNT DECREASED 6 0.0002
703 SUBDURAL HAEMATOMA 3 0.0002
704 ERYTHEMA 43 0.0002
705 POST PROCEDURAL COMPLICATION 4 0.0002
706 HYPERTHYROIDISM 3 0.0002
707 BODY TEMPERATURE DECREASED 2 0.0002
708 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
709 BLOOD PRESSURE ABNORMAL 4 0.0002
710 PNEUMONIA ASPIRATION 5 0.0002
711 UNEVALUABLE EVENT 15 0.0002
712 ECONOMIC PROBLEM 3 0.0002
713 OSTEOPENIA 3 0.0002
714 DRY THROAT 2 0.0002
715 TOOTH ABSCESS 2 0.0002
716 SUBARACHNOID HAEMORRHAGE 2 0.0002
717 NEUTROPHIL COUNT INCREASED 2 0.0002
718 TENDONITIS 3 0.0002
719 EJECTION FRACTION DECREASED 3 0.0002
720 VENTRICULAR EXTRASYSTOLES 2 0.0002
721 CONVULSION 11 0.0002
722 TENDERNESS 2 0.0002
723 HERPES ZOSTER 11 0.0002
724 EAR INFECTION 5 0.0002
725 HYPOTHYROIDISM 6 0.0002
726 BLOOD GLUCOSE DECREASED 9 0.0002
727 CARDIAC FAILURE 15 0.0002
728 RECTAL HAEMORRHAGE 8 0.0002
729 DYSPNOEA EXERTIONAL 7 0.0002
730 POOR QUALITY SLEEP 4 0.0002
731 BLOOD POTASSIUM INCREASED 3 0.0002
732 RASH PRURITIC 10 0.0002
733 FAECES DISCOLOURED 4 0.0002
734 SWELLING FACE 12 0.0002
735 MANIA 3 0.0002
736 VENTRICULAR FIBRILLATION 2 0.0002
737 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
738 ORAL PAIN 4 0.0002
739 PERICARDITIS 3 0.0002
740 EYE INFECTION 2 0.0002
741 EYELID OEDEMA 2 0.0002
742 POST PROCEDURAL HAEMORRHAGE 2 0.0002
743 COLD SWEAT 3 0.0002
744 PSYCHOTIC DISORDER 5 0.0002
745 DISEASE RECURRENCE 8 0.0002
746 MYOCLONUS 2 0.0002
747 INFUSION RELATED REACTION 11 0.0002
748 ADRENAL INSUFFICIENCY 2 0.0002
749 NO THERAPEUTIC RESPONSE 2 0.0002
750 DRUG ADMINISTRATION ERROR 5 0.0002
751 HAEMORRHAGE 17 0.0002
752 CARDIOMEGALY 2 0.0002
753 BLOOD GLUCOSE ABNORMAL 3 0.0002
754 HYPERCALCAEMIA 2 0.0002
755 CARDIAC FAILURE CONGESTIVE 13 0.0002
756 CONJUNCTIVITIS 3 0.0002
757 GENERALISED OEDEMA 2 0.0002
758 PHOTOPHOBIA 3 0.0002
759 HYPOPHAGIA 4 0.0002
760 PULMONARY FIBROSIS 3 0.0002
761 ROTATOR CUFF SYNDROME 2 0.0002
762 INFUSION SITE PAIN 2 0.0002
763 NIGHT SWEATS 5 0.0002
764 INFLAMMATION 8 0.0002
765 UNRESPONSIVE TO STIMULI 4 0.0002
766 EAR PAIN 3 0.0002
767 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
768 KIDNEY INFECTION 3 0.0002
769 CHOLELITHIASIS 5 0.0002
770 IMPAIRED HEALING 5 0.0002
771 INCORRECT PRODUCT STORAGE 2 0.0002
772 ORAL CANDIDIASIS 2 0.0002
773 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
774 SARS-COV-2 TEST POSITIVE 2 0.0002
775 DISORIENTATION 6 0.0002
776 BLOOD PRESSURE DECREASED 10 0.0002
777 LIP SWELLING 5 0.0001
778 URINARY RETENTION 5 0.0001
779 QUALITY OF LIFE DECREASED 2 0.0001
780 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
781 PRODUCT PREPARATION ERROR 3 0.0001
782 SKIN LESION 4 0.0001
783 COORDINATION ABNORMAL 2 0.0001
784 APHONIA 2 0.0001
785 MASS 2 0.0001
786 RASH MACULAR 5 0.0001
787 MOUTH ULCERATION 3 0.0001
788 CONFUSIONAL STATE 23 0.0001
789 SKIN REACTION 2 0.0001
790 HYPERSENSITIVITY 26 0.0001
791 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
792 PRODUCT PRESCRIBING ISSUE 3 0.0001
793 HYPERGLYCAEMIA 5 0.0001
794 MELAENA 3 0.0001
795 AGITATION 10 0.0001
796 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
797 URINARY INCONTINENCE 4 0.0001
798 HEPATOTOXICITY 3 0.0001
799 PULMONARY MASS 2 0.0001
800 GASTROINTESTINAL DISORDER 12 0.0001
801 THROAT IRRITATION 6 0.0001
802 EPISTAXIS 10 0.0001
803 CHROMATURIA 3 0.0001
804 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
805 TINNITUS 6 0.0001
806 FEELING HOT 8 0.0001
807 PHARYNGEAL OEDEMA 2 0.0001
808 EMOTIONAL DISORDER 4 0.0001
809 DELUSION 2 0.0001
810 SWELLING 12 0.0001
811 BRAIN FOG 2 0.0001
812 PRURITUS 49 0.0001
813 ARRHYTHMIA 6 0.0001
814 FALL 42 0.0001
815 PRODUCT STORAGE ERROR 11 0.0001
816 PAIN 77 0.0001
817 COUGH 35 0.0001
818 CHEST PAIN 23 0.0001
819 MENTAL IMPAIRMENT 3 0.0001
820 OSTEOPOROSIS 5 0.0001
821 OSTEONECROSIS OF JAW 3 0.0001
822 VIRAL INFECTION 4 0.0001
823 HEMIPARESIS 2 0.0001
824 HYPERHIDROSIS 15 0.0001
825 STOMATITIS 7 0.0001
826 DRUG INEFFECTIVE 152 0.0001
827 LOCAL SWELLING 2 0.0001
828 DEPRESSION 26 0.0001
829 LYMPHOCYTE COUNT DECREASED 2 0.0001
830 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
831 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
832 MYELOSUPPRESSION 4 0.0001
833 BONE DISORDER 2 0.0001
834 PANIC ATTACK 4 0.0001
835 SUICIDAL IDEATION 10 0.0001
836 PROCEDURAL PAIN 3 0.0001
837 DEEP VEIN THROMBOSIS 7 0.0001
838 DECREASED APPETITE 25 0.0001
839 EMOTIONAL DISTRESS 13 0.0001
840 BREAST CANCER 10 0.0001
841 DYSARTHRIA 4 0.0001
842 HALLUCINATION 8 0.0001
843 PAIN IN JAW 3 0.0001
844 COLITIS 4 0.0001
845 HAEMORRHOIDS 2 0.0001
846 DEATH 88 0.0001
847 DISABILITY 2 0.0001
848 PREGNANCY 2 0.0001
849 ABORTION SPONTANEOUS 4 0.0001
850 BLOOD POTASSIUM DECREASED 3 0.0001
851 FULL BLOOD COUNT DECREASED 2 0.0001
852 DIARRHOEA 64 0.0001
853 VERTIGO 6 0.0001
854 SWOLLEN TONGUE 3 0.0001
855 PRODUCT USE ISSUE 18 0.0001
856 PULMONARY EMBOLISM 9 0.0001
857 OSTEOARTHRITIS 4 0.0001
858 MENTAL DISORDER 4 0.0001
859 NAUSEA 72 0.0001
860 ASTHENIA 34 0.0001
861 DEHYDRATION 12 0.0001
862 SYNCOPE 9 0.0001
863 SOMNOLENCE 18 0.0001
864 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
865 SNEEZING 2 0.0001
866 TYPE 2 DIABETES MELLITUS 3 0.0001
867 PARAESTHESIA 14 0.0001
868 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
869 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
870 HEART RATE IRREGULAR 2 0.0001
871 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
872 GASTRIC DISORDER 3 0.0001
873 ABDOMINAL DISTENSION 9 0.0001
874 BACK PAIN 20 0.0001
875 LOSS OF CONSCIOUSNESS 11 0.0001
876 RENAL DISORDER 4 0.0001
877 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
878 BURNING SENSATION 6 0.0001
879 HEART RATE DECREASED 3 0.0001
880 TREMOR 14 0.0001
881 PRODUCT PRESCRIBING ERROR 2 0.0001
882 VOMITING 39 0.0001
883 FIBROMYALGIA 2 0.0001
884 NEURALGIA 2 0.0001
885 MALAISE 36 0.0001
886 BRONCHITIS 6 0.0001
887 ABASIA 2 0.0001
888 INFLUENZA 9 0.0001
889 AGEUSIA 2 0.0001
890 ABDOMINAL PAIN LOWER 2 0.0001
891 HEPATITIS 2 0.0001
892 SINUSITIS 8 0.0001
893 DIPLOPIA 2 0.0001
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
895 SEDATION 2 0.0001
896 SPEECH DISORDER 4 0.0001
897 NASOPHARYNGITIS 14 0.0001
898 ABNORMAL BEHAVIOUR 3 0.0001
899 PANCREATITIS 4 0.0001
900 HYPERTENSION 16 0.0001
901 FREQUENT BOWEL MOVEMENTS 2 0.0001
902 DYSKINESIA 3 0.0001
903 DYSPHAGIA 7 0.0001
904 DIVERTICULITIS 2 0.0001
905 WEIGHT DECREASED 20 0.0001
906 DEMENTIA 2 0.0001
907 SEIZURE 8 0.0001
908 FLUSHING 7 0.0001
909 DRUG WITHDRAWAL SYNDROME 6 0.0001
910 SURGERY 4 0.0001
911 NASAL CONGESTION 4 0.0001
912 ACUTE MYOCARDIAL INFARCTION 2 0.0001
913 LABORATORY TEST ABNORMAL 2 0.0001
914 INSOMNIA 18 0.0001
915 ARTHRALGIA 28 0.0001
916 IRRITABILITY 4 0.0001
917 SKIN DISCOLOURATION 3 0.0001
918 TOXICITY TO VARIOUS AGENTS 11 0.0001
919 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
920 BLOOD CHOLESTEROL INCREASED 3 0.0001
921 COGNITIVE DISORDER 3 0.0001
922 AMNESIA 4 0.0001
923 DYSPEPSIA 6 0.0001
924 EYE DISORDER 2 0.0001
925 EYE PRURITUS 2 0.0001
926 MUSCULOSKELETAL PAIN 3 0.0001
927 MUSCULOSKELETAL STIFFNESS 5 0.0001
928 DEPRESSED MOOD 3 0.0001
929 VISUAL IMPAIRMENT 7 0.0001
930 DISTURBANCE IN ATTENTION 3 0.0001
931 HAEMATOCHEZIA 3 0.0001
932 HEADACHE 34 0.0001
933 OROPHARYNGEAL PAIN 5 0.0001
934 MEDICATION ERROR 3 0.0001
935 WEIGHT INCREASED 12 0.0001
936 CARDIAC DISORDER 5 0.0001
937 ABDOMINAL PAIN UPPER 11 0.0001
938 INTESTINAL OBSTRUCTION 2 0.0001
939 MUSCULAR WEAKNESS 6 0.0001
940 COVID-19 9 0.0001
941 PLASMA CELL MYELOMA 2 0.0001
942 THROMBOSIS 4 0.0000
943 ILL-DEFINED DISORDER 3 0.0000
944 EXTRA DOSE ADMINISTERED 2 0.0000
945 INFLUENZA LIKE ILLNESS 4 0.0000
946 FATIGUE 37 0.0000
947 RHINORRHOEA 3 0.0000
948 DIZZINESS 23 0.0000
949 VAGINAL HAEMORRHAGE 2 0.0000
950 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
951 NEOPLASM MALIGNANT 3 0.0000
952 NEPHROLITHIASIS 2 0.0000
953 BLOOD GLUCOSE INCREASED 8 0.0000
954 OCULAR HYPERAEMIA 2 0.0000
955 FLUID RETENTION 2 0.0000
956 DERMATITIS ATOPIC 2 0.0000
957 ABDOMINAL DISCOMFORT 6 0.0000
958 ALOPECIA 7 0.0000
959 FLATULENCE 2 0.0000
960 BALANCE DISORDER 3 0.0000
961 BONE PAIN 2 0.0000
962 JOINT SWELLING 4 0.0000
963 ADVERSE EVENT 3 0.0000
964 CONSTIPATION 7 0.0000
965 MIGRAINE 3 0.0000
966 GAIT DISTURBANCE 6 0.0000
967 SLEEP DISORDER 2 0.0000
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
969 MUSCLE SPASMS 5 0.0000
970 DYSGEUSIA 2 0.0000
971 HYPOAESTHESIA 4 0.0000
972 HOT FLUSH 2 0.0000
973 DIABETES MELLITUS 2 0.0000
974 ARTHRITIS 2 0.0000
975 FEELING ABNORMAL 6 0.0000
976 DRY MOUTH 2 0.0000
977 DRUG ABUSE 2 0.0000
978 PAIN IN EXTREMITY 7 0.0000
979 CEREBROVASCULAR ACCIDENT 4 0.0000
980 OVERDOSE 5 0.0000
981 MYOCARDIAL INFARCTION 4 0.0000
982 DEVICE ISSUE 2 0.0000
983 VISION BLURRED 3 0.0000
984 MEMORY IMPAIRMENT 3 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
986 PERIPHERAL SWELLING 3 0.0000
987 RHEUMATOID ARTHRITIS 2 0.0000
988 INCORRECT DOSE ADMINISTERED 4 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
990 NO ADVERSE EVENT 3 0.0000
991 INJECTION SITE ERYTHEMA 2 0.0000
992 PSORIASIS 2 0.0000
993 DRY SKIN 2 0.0000
994 PRODUCT DOSE OMISSION ISSUE 3 0.0000